Typbar TCV
Brand Name: Typbar TCV®
Composition: Typhoid Vi Conjugate Vaccine IP
Format: Single Dose 0.5 mL PFS (Pre-filled Syringe)
Administration: For Intramuscular use only
Manufacturer: Bharat Biotech
Product Description
Medical Info
Typbar TCV® is a pioneering Typhoid Vi Conjugate Vaccine developed by Bharat Biotech to provide robust, long-lasting protection against typhoid fever caused by Salmonella typhi. Formulated as a single-dose 0.5 mL pre-filled syringe for intramuscular use, this advanced vaccine chemically conjugates the Vi capsular polysaccharide antigen to a tetanus toxoid carrier protein. This unique conjugation overcomes the limitations of older polysaccharide vaccines by triggering a T-cell-dependent immune response, making it highly effective even in infants and young children over six months of age. It serves as a vital clinical tool in global immunization and outbreak prevention.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
